Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study

Ismay A E de Beijer¹, Emma C Hardijzer², Riccardo Haupt³, Desiree Grabow⁴, Julia Balaguer⁵, Edit Bardi^{6

7}, Adela Cañete Nieto⁵, Audronė Ciesiūniene⁸, Vanessa Düster⁹, Anna-Liesa Filbert⁴, Hannah Gsell¹⁰, Monika Kapitančukė⁸, Ruth Ladenstein⁹, Thorsten Langer¹¹, Monica Muraca³, Selina R van den Oever², Sofie Prikken¹², Jelena Rascon⁸, Maria Teresa Tormo¹³, Anne Uyttebroeck¹², Gertrui Vercruysse¹², Helena J H van der Pal², Leontien C M Kremer^{2

14

15}, Saskia M F Pluijm²; PanCareSurPass consortium

Affiliations

¹ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. i.a.e.debeijer-3@prinsesmaximacentrum.nl.
² Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
³ IRCCS Istituto Giannina Gaslini, Genoa, Italy.
⁴ Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, of the Johannes Gutenberg University Mainz, Mainz, Germany.
⁵ Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁶ St. Anna Children's Hospital, Vienna, Austria.
⁷ Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
⁸ Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
⁹ St. Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Department of Paediatrics, Medical University of Vienna, Vienna, Austria.
¹⁰ CCI Europe, Vienna, Austria.
¹¹ Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lübeck, Germany.
¹² University Hospitals Leuven, KU Leuven, Louvain, Belgium.
¹³ Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
¹⁴ University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
¹⁵ Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 38466480
PMCID: PMC12081557
DOI: 10.1007/s11764-024-01547-w

Published Erratum

Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study

Ismay A E de Beijer et al. J Cancer Surviv. 2025 Jun.

. 2025 Jun;19(3):1111.

doi: 10.1007/s11764-024-01547-w.

Authors

Affiliations

¹ Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. i.a.e.debeijer-3@prinsesmaximacentrum.nl.
² Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.
³ IRCCS Istituto Giannina Gaslini, Genoa, Italy.
⁴ Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, of the Johannes Gutenberg University Mainz, Mainz, Germany.
⁵ Hospital Universitario y Politécnico La Fe, Valencia, Spain.
⁶ St. Anna Children's Hospital, Vienna, Austria.
⁷ Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria.
⁸ Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
⁹ St. Anna Children's Hospital and Children's Cancer Research Institute, Department of Studies and Statistics for Integrated Research and Projects, Department of Paediatrics, Medical University of Vienna, Vienna, Austria.
¹⁰ CCI Europe, Vienna, Austria.
¹¹ Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lübeck, Germany.
¹² University Hospitals Leuven, KU Leuven, Louvain, Belgium.
¹³ Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
¹⁴ University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
¹⁵ Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 38466480
PMCID: PMC12081557
DOI: 10.1007/s11764-024-01547-w

No abstract available

PubMed Disclaimer

Erratum for

Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.
de Beijer IAE, Hardijzer EC, Haupt R, Grabow D, Balaguer J, Bardi E, Cañete Nieto A, Ciesiūniene A, Düster V, Filbert AL, Gsell H, Kapitančukė M, Ladenstein R, Langer T, Muraca M, van den Oever SR, Prikken S, Rascon J, Tormo MT, Uyttebroeck A, Vercruysse G, van der Pal HJH, Kremer LCM, Pluijm SMF; PanCareSurPass consortium. de Beijer IAE, et al. J Cancer Surviv. 2025 Apr;19(2):659-671. doi: 10.1007/s11764-023-01498-8. Epub 2023 Nov 28. J Cancer Surviv. 2025. PMID: 38015382 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- PubMed Central
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study

Affiliations

Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources